|
|
|
| Clinical Value of Collioid Chromiun 32P Combining Pingyangmycin to Treat Deep Subcutaneous Hemangioma of Infants |
| XIAO Huan, PAN Wei-min, YAN Wei-wen, XIE Quan, CHEN Hong-yan |
| Dept of Nuclear Medicine, Hainan School of Medicine Affiliated Hospital, Haikou 570102 China |
|
|
|
|
Abstract Objective To explore the clinical value of Collioid Chromiun Phosphate-32 combining pingyangmycin to treat deep subcutaneous hemangioma of infants by injection. Methods 62 subcutaneous hemangioma in 41 infants were selected and treated by Collioid Chromiun Phosphate-32 combining pingyangmycin. The volume of hemangioma was calculated by color Doppler ultrasound inspection. And the hemangioma was then injected 5.55~9.25×108 Bq(15~25 μCi/cm3) Collioid Chromiun Phosphate-32 (with total dosage no more than 1.85×107 Bq(0.5 mCi) for each child) and 150~250 μg/cm3 pingyangmycin(with total dosage no more than 4mg for each child). Results 41 infants was conducted injection with each one injected 1~3 times. On average for the 61 hemangioma, 1.58 injections were done on each one. And the average treatment time was 6 months. The total effective rate was 98.4%. and no systematic or serious local complications were found among all infants within a 5-year follow-up. Conclusion Colloid 32 phosphoric acid chromium joint pingyangmycin has a curative effect on deep infant skin hemangioma. Giving corresponding education can improve the cure rate.
|
|
Received: 11 July 2015
|
|
|
|
|
|
| [1] |
. [J]. , 2010, 19(4): 506-507. |
|
|
|
|
